Agency News
'Why buy a network that even Dentsu couldn’t fix?': Inside the gamble of Dentsu's international arm sale
Govt considering stricter regulations on ads for anti-diabetes, sex hormone, and oncology drugs
To curb misleading claims, the government has drafted new rules that would require prior approval for advertising anti-diabetes, sex hormone, and oncology drugs.
India's top drug advisory body, the DTAB, suggested restricting advertising for these drugs after considering a proposal from Goa's Food and Drugs Administration. This move comes after several years of deliberation on the matter.
(Image source: Unsplash)
To prevent misleading claims, the government is considering stricter regulations on advertisements for anti-diabetes, sex hormone, and oncology drugs. This includes requiring prior government approval for advertising medicines containing Schedule G drugs. The proposed changes will be made to the Drugs and Cosmetics Rules, 1945, as per an ET report.
To curb misleading claims, the government has drafted new rules that would require prior approval for advertising anti-diabetes, sex hormone, and oncology drugs. These drugs, categorized under Schedule G, would join Schedule H, H1, and X medications which already demand government clearance for advertising.
The report states that the proposed amendments to the Drugs and Cosmetics Rules, 1945, are open for public feedback for the next 45 days. The final rules will be based on the received comments.
Additionally, the government has emphasized existing restrictions under the Drugs and Magic Remedies Act, 1954, which prohibits advertisements claiming to cure certain diseases.
SPOTLIGHT
According to LinkedIn’s research with over 1,700 B2B tech buyers, video storytelling has emerged as the most trusted, engaging, and effective format for B2B marketers. But what’s driving this shift towards video in B2B? (Image Source: Unsplash)
Read MoreExplained: Standing Committee’s draft report on India’s fight against Fake News
India’s parliamentary panel warns fake news threatens democracy, markets and media credibility, urging stronger regulation, fact-checking, AI oversight and global cooperation.